title: Response to discussion by Dr Philip Hébert. Use of recombinant activated factor VIIa (FVIIa) in severe head injury.
authors.forename: Venkatesh
authors.initials: V
authors.lastname: Aiyagari
authors.forename: Michael N
authors.initials: MN
authors.lastname: Diringer
mesh_terms: D000328:Adult; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D004992:Ethics, Medical; D015942:Factor VIIa / Q000627:therapeutic use*; D006805:Human Experimentation / Q000941:ethics; D006801:Humans; D007258:Informed Consent; D008297:Male
chemical_list: D015942:Factor VIIa